In This Issue..
Effective with date of service June 30, 2002, state-created codes Y2058 and Y2089 will be end-dated to comply with the implementation of national procedure codes mandated by the Health Insurance Portability and Accountability Act (HIPAA).
Effective with date of service July 1, 2002, Rural Health Clinic (RHC)
and Federally Qualified Health Center (FQHC) providers must bill procedure
code T1015 - Clinic visit/encounter, all inclusive -for all core services.
An RHC/FQHC core service visit must be billed using the provider's six-digit
provider number with alpha suffix "A."
| End-dated Code | New Code |
| Y2058 - RHC Core Service | T1015 - Clinic visit/encounter, all inclusive |
| Y2089 - FQHC Core Service | T1015 - Clinic visit/encounter, all inclusive |
EDS, 1-800-688-6696 or 919-851-8888
For males under the age of 25, the physician (or designee) must call 919-857-4037 to obtain a prior approval form. The physician must complete the requested information for medical necessity and return the completed form to the following address:
N.C. Division of Medical Assistance
Attn: Sharman Leinwand, MPH, R.Ph.
2511 Mail Service Center
Raleigh, North Carolina 27699-2511
FAX: 919-733-2796
An authorization code will be assigned to all requests that are approved.
This code must be included on the prescription to notify the pharmacist
that the prescription has been approved for dispensing. Claims for prescriptions
dispensed to recipients under the age of 25 must be submitted on paper
and not through Point of Sale.
EDS, 1-800-688-6696 or 919-851-8888
Darlene Cagle
Medical Policy Section
Division of Medical Assistance
2511 Mail Service Center
Raleigh, NC 27699-2511
The initial comment period for each proposed policy is 45 days. An additional
15-day comment period will follow if a proposed policy is revised as a
result of the initial comment period.
Darlene Cagle, Medical Policy Section
DMA, 919-857-4020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EDS, 1-800-688-6696 or 919-851-8888
For more information regarding third party certification, please refer
to the WEDI/SNIP Testing and Certification white paper at http://snip.wedi.org.
Additional information on third party certification and remaining transaction
implementation and testing dates will be provided in future Medicaid bulletinsand on DMA's HIPAA website.
EDS, 1-800-688-6696 or 919-851-8888
EDS, 1-800-688-6696 or 919-851-8888
| Radioactive Imaging Agent | Code | Pricing |
| Technetium TC 99M Sestamibi (Cardiolite) | A9500 | Invoice |
| Thallous Chloride TL201 | A9505 | Invoice |
| Supply of radiopharmaceutical diagnostic imaging
agent,
not otherwise classified such as Tetrofosim (Myoview) |
78990 | Invoice |
The invoice must be attached and include the:
| Pharmacological Stress Agents | Code | Pricing |
| Dipyridamole (Persantine), per 10 mg. | J1245 | Fee schedule |
| Dobutamine (Dobutrex), per 250 mg. | J1250 | Fee schedule |
| Adenosine (Adenoscan), per 90 mg. | J0151 | Fee schedule |
EDS, 1-800-688-6696 or 919-851-8888
WebMD Corporation (formerly Envoy)
15 Century Blvd., Suite 600
Nashville, TN 37214
1-800-366-5716 (marketing)
www.webmd.com
MedifaxEDI
1283 Murfreesboro Rd
Nashville, TN 37217-2421
1-800-819-5003 (marketing)
marketing@medifax.com
Healthcare Data Exchange Corporation (HDX)
300 Lindenwood Dr., Suite 200
Malvern, PA 19355-1751
1-610-219-1859 (marketing, Brian Gill)
brian.gill@hdx.com
Passport Health Communications, Inc.
720 Cool Springs Blvd., Suite 450
Franklin, TN 37067
1-888-661-5657 (marketing, Lloyd Baker)
Lloyd.baker@passporthealth.com
Providers interested in subscribing for EDI services are encouraged
to contact the above vendors. Updated lists will be published in the general
Medicaid bulletin as new vendors are approved and enrolled.
Susan Ryan, Recipient and Provider Services
DMA, 919-857-4019
An invoice is required for those drugs that are billed with J3490. The
invoice must include the name of the Medicaid recipient, the Medicaid identification
(MID) number, the name of the medication, the dosage given, the National
Drug Code (NDC) number from the vial(s) used, the number of vials used
per NDC code, and the cost per dose. The NDC number is printed on each
drug product.
|
|
|
|
|
|
|
Albumin (human), 5%, 50 ml** |
|
|
|
Albumin (human), 25%, 50 ml |
|
|
|
Alteplase Recombinant, 1 mg** |
|
|
|
Amikacin Sulfate, 500 mg |
|
|
|
Azithromycin, oral suspension 1 unit = 1 gm packet (Zithromax) |
|
|
|
BCG live (intravesical), per installation |
|
|
|
Baclofen Kit, 2 5 ml Ampules |
|
|
|
Baclofen Kit, 4 5 ml Ampules |
|
|
|
Butorphanol Tartrate, 1 mg (Stadol) |
|
|
|
Cefepime HCL, 500 mg |
|
|
|
Cimetadine HCL, 300 mg |
|
|
|
Ciprofloxacin for intravenous infusion, 200 mg |
|
|
|
Denileukin Diftitox, 300 mcg (Ontak) |
|
|
|
Factor IX (antihemophilic factor, purified, non-recombinant), per I.U. |
|
|
|
Factor IX (antihemophilic factor, recombinant), per I.U. |
|
|
|
Lupron Depot Pediatric, 7.5 mg |
|
|
|
Lupron Depot Pediatric, 11.25 mg |
|
|
|
Lupron Depot Pediatric, 15 mg |
|
|
|
Octreotide Acetate, 100 mcg (Sandostatin)** |
|
|
|
Octreotide Acetate, 1mg (Sandostatin). Pricing based on 20 mg** |
|
|
|
Octreotide Acetate, 1mg (Sandostatin). Pricing based on 10 mg** |
|
|
|
Pentamidine Isethionate, 300 mg |
|
|
|
Reteplase, 18.1 mg (Retavase)** |
|
|
|
Sodium Bicarbonate 7.5% up to 50 ml |
|
|
|
Sodium Hyaluronate, 5 mg for intra-articular injection** |
* Indicates that an invoice is required with the claim.
** Indicates a description change.
End-dated Codes for Injectable Drugs
The following codes will be end-dated from the Physician's Drug Program effective with date of service September 30, 2002. Vaccine codes are being end-dated in accordance with information obtained from the drug manufacturers and the Centers for Disease Control. These vaccines are no longer manufactured or available in the United States or are no longer recommended.
Injectable Drugs
|
|
|
|
|
Benzquinamide HCl, up to 50 mg |
|
|
Biperiden, 5 mg (Akineton) |
|
|
Cefonicid Sodium, 1 gm |
|
|
Chlorpheniramine Maleate, per 10 mg |
|
|
Chlorprothixene, up to 50 mg |
|
|
Cortisone, up to 50 mg |
|
|
Hydrochlorides of Opium Alkaloids (Pantopan) |
|
|
Hydroxyprogesterone Caproate, 125 mg/ml |
|
|
Hydroxyprogesterone Caproate, 250 mg/ml |
|
|
Imipramine HCl, up to 25 mg |
|
|
Lupron Depot Pediatric, 11.25 mg |
|
|
Lupron Depot Pediatric, 15 mg |
|
|
Mephentermine, up to 30 mg |
|
|
Methicillin Sodium, up to 1 gm (Staphcillin) |
|
|
Methotrimeprazine, up to 20 mg |
|
|
Methoxamine, up to 20 mg (Basoxyl) |
|
|
Nandrolone Phenpropionate, up to 50 mg (Duradolin) |
|
|
Prednisolone Sodium Phosphate, up to 20 mg |
|
|
Prendisolone Terbutate, up to 20 mg |
|
|
Progesterone, per 50 mg |
|
|
Propiomazine HCl, up to 20 mg |
|
|
Thiothixene, up to 4 mg (Navane) |
|
|
Trimethapan Camsylate, up to 500 mg |
Vaccines/Toxoids
|
|
|
|
|
Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, for intramuscular use |
|
|
Influenza virus vaccine, whole virus, for intramuscular or jet injection use |
|
|
Rabies vaccine, for intradermal use |
|
|
Diptheria, tetanus toxoids, and whole cell pertussis vaccine (DTP), for intramuscular use |
|
|
Measles and rubella virus vaccine, live for subcutaneous or jet injection use |
|
|
Rubella and mumps virus vaccine, live, for subcutaneous use |
|
|
Poliovirus vaccine, (any type(s) (OPV), live, for oral use |
|
|
Diphtheria toxoid, for intramuscular use |
|
|
Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for intramuscular use |
|
|
Cholera vaccine for injectable use |
EDS, 1-800-688-6696 or 919-851-8888
Physicians will continue to bill on the CMS-1500 claim form using the appropriate drug code, indicating the number of units administered as specified in the listing. Free vaccines from the Vaccines for Children (VFC) program are not included in this list.
New Codes
|
|
|
|
|
|
|
|
Albumin (human), 5%, 50 ml |
$ 26.28
|
|
|
|
Albumin (human), 25%, 50 ml |
88.65
|
|
|
|
Alteplase recombinant, 1 mg** |
24.82
|
|
|
|
Reteplase, 18.1 mg (Retavase)** |
1,240.94
|
** Indicates a description change.
Immune Globulins
|
|
|
|
|
|
Immune globulin (IgIV), human, for intravenous use, 500 mg |
$ 42.84
|
|
|
Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use, 1 ml |
13.31
|
|
|
Hepatitis B immune globulin (HBIg), human, for intramuscular use, 0.5 ml |
68.04
|
|
|
Rabies immune globulin (RIg), human, for intramuscular and/or subcutaneous use, 2 ml |
151.20
|
|
|
Rabies immune globulin, heart-treated (RIg-HT), human, for intramuscular and/or subcutaneous use, 2 ml |
143.68
|
|
|
Respiratory syncytial virus immune globulin (RSV-IgIV), human, for intravenous use, 1 ml |
15.47
|
|
|
Rho(D) immune globulin (RhIg), human, full-dose, for intramuscular use, 1500 IU/300 mcg |
99.90
|
|
|
Rho(D) immune globulin (RhIg), human, mini-dose, for intramuscular use, 120 IU/50 mcg |
34.02
|
|
|
Rho(D) immune globulin (RhIglV), human, for intravenous use, 100 IU |
20.38
|
|
|
Tetanus immune globulin (TIg), human, for intramuscular use, 250 u/1 ml |
108.00
|
|
|
Varicella-zoster immune globulin, human, for intramuscular use, 125 u/1.25 ml |
112.50
|
|
|
Gamma Globulin, Intramuscular, 1 cc (Gammar) |
3.24
|
|
|
Gamma Globulin, Intramuscular, 2 cc |
6.48
|
|
|
Gamma Globulin, Intramuscular, 3 cc |
9.72
|
|
|
Gamma Globulin, Intramuscular, 4 cc |
12.96
|
|
|
Gamma Globulin, Intramuscular, 5 cc |
16.20
|
|
|
Gamma Globulin, Intramuscular, 6 cc |
19.44
|
|
|
Gamma Globulin, Intramuscular, 7 cc |
22.68
|
|
|
Gamma Globulin, Intramuscular, 8 cc |
25.92
|
|
|
Gamma Globulin, Intramuscular, 9 cc |
29.16
|
|
|
Gamma Globulin, Intramuscular, 10 cc |
32.40
|
|
|
Gamma Globulin, Intramuscular, over 10 cc (use correct combinations of services) |
^^
|
^^ Designates special pricing.
Vaccines/Toxoids
|
|
|
|
|
|
Bacillus Calmette-Guerin vaccine (BCG), for tuberculosis, live, for percutaneous use, per vial |
$ 151.50
|
|
|
Hepatitis A vaccine, adult dosage, for intramuscular use, 1 ml |
57.83
|
|
|
Hepatitis A vaccine, pediatric/adolescent dosage-2 dose schedule, for intramuscular use, 0.5 ml |
29.52
|
|
|
Hemophilus influenza b vaccine (Hib), Hb0C conjugate (4 dose schedule), for intramuscular use, 0.5 ml |
25.54
|
|
|
Hemophilus influenza b vaccine (Hib) PRP-OMP conjugate (3 Dose schedule), for intramuscular use, 0.5 ml |
21.86
|
|
|
Hemophilus influenza b vaccine (Hib) PRP-T conjugate (4 dose schedule), for intramuscular use, 0.5 ml |
22.58
|
|
|
Influenza virus vaccine, split virus, 3 years and above dosage, for intramuscular or jet injection use, 0.5 ml |
6.77
|
|
|
Rabies vaccine, for intramuscular use, 2 ml |
140.32
|
|
|
Rotavirus vaccine, tetravalent, live, for oral use |
17.37
|
|
|
Tetanus toxoid adsorbed, for intramuscular or jet injection use, 0.5 ml |
7.88
|
|
|
Mumps virus vaccine, live, for subcutaneous or jet injection use |
18.80
per dose |
|
|
Measles virus vaccine, live, for subcutaneous or jet injection use, 0.5 ml |
14.94
|
|
|
Rubella virus vaccine, live, for subcutaneous or jet injection use, 0.5 ml |
15.65
|
|
|
Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous or jet injection use |
40.75
per dose |
|
|
Poliovirus vaccine, inactivated, (IPV), for subcutaneous use |
26.05
per dose |
|
|
Varicella virus vaccine, live, for subcutaneous use, 0.5 ml |
61.52
|
|
|
Mumps virus vaccine, live, for subcutaneous or jet injection use |
18.80
per dose |
|
|
Tetanus and diphtheria toxoids (Td) adsorbed for use in individuals seven years or older, for intramuscular or jet injection, 0.5 ml |
10.35
|
|
|
Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DtaP-Hib), for intramuscular use |
42.30
per dose |
|
|
Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use, 0.5 ml |
12.88
|
|
|
Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous or jet injection use, 0.05 mg |
$ 72.31
|
|
|
Hepatitis B vaccine, adult dosage, for intramuscular use, 1 ml |
63.42
|
|
|
Hepatitis B vaccine, dialysis or immunosuppressed
patient dosage
(4 dose schedule), for intramuscular use, 40 mcg/2ml |
105.38
|
Corrections to the Injectable Drug List Update Published in the June
2002 Medicaid Bulletin
|
|
|
|
|
|
|
|
Amikacin Sulfate, 500 mg (Amikin) ** |
$ 30.83
|
|
|
|
Azithromycin, oral suspension 1 unit = 1 gm packet (Zithromax), only oral drug on list |
20.07
|
|
|
|
Testosterone Cypionate, up to 100 mg ** |
4.10
|
** Indicates a description change.
Billing Guidelines When Billing by Invoice for J3490 (Miscellaneous Drug Code)
The following drugs are billed with the miscellaneous drug code, J3490.
An invoice must be submitted with the claim when these drugs are billed.
The invoice must include the name of the Medicaid recipient, the Medicaid
identification (MID) number, the name of the medication, the dosage given,
the National Drug Code (NDC) number from the vial(s) used, the number of
vials used per NDC code, and the cost per dose. The NDC number is printed
on each drug product.
|
|
|
|
|
|
|
Baclofen kit, 2 5 ml ampules |
|
Baclofen kit, 2 5 ml ampules |
|
|
Baclofen kit, 4 5 ml ampules |
|
Baclofen kit, 4 5 ml ampules |
|
|
Lupron depot pediatric, 7.5 mg |
|
Lupron depot pediatric 7.5 mg, pricing based on 7.5 mg package |
|
|
Lupron depot pediatric, 11.25 mg |
|
Lupron depot pediatric 11.25 mg, pricing based on 11.25 mg package |
|
|
Lupron depot pediatric, 15 mg |
|
Lupron depot pediatric 15 mg, pricing based on 15 mg package |
|
|
Octreotide acetate LAR depot, 1 mg |
|
Octreotide acetate, 1 mg, pricing based on 20 mg (Sandostatin) |
| W5198 | Octreotide acetate LAR depot, 1 mg |
|
Octreotide acetate, 1 mg, pricing based on 10 mg (Sandostatin) |
| Y1856 | Sodium bicarbonate |
|
Sodium bicarbonate, 7.5%, up to 50 ml |
EDS, 1-800-688-6696 or 919-851-8888
The 2001 CPT description of code 20550 Injection, tendon sheath,
ligament, trigger points or ganglion cyst was changed to Injection;
tendon sheath, ligament, ganglion cyst in CPT 2002. Three
codes were added to 2002 CPT to differentiate the techniques associated
with multiple muscle group injections for trigger points and injection
of a tendon at the site of origin or insertion.
|
|
|
|
|
|
|
|
Injection; tendon origin/insertion | |
|
|
|
Injection; single or multiple trigger point(s), one or two muscle group(s) | |
|
|
|
Injection; single or multiple trigger point(s), three or more muscle group(s) | |
|
|
|
Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations |
Denied claims related to billing these new codes may be corrected and
resubmitted.
EDS, 1-800-688-6696 or 919-851-8888
EDS, 1-800-688-6696 or 919-851-8888
Procedure code W8002 (Initial Oral Screening) will be replaced with
the following procedure codes:
| Procedure Code | Description |
| D0150 | Comprehensive oral evaluation |
| D1203 | Topical application of fluoride (prophylaxis not included) - child |
| D1330 | Oral hygiene instructions |
The following criteria apply for the Initial Oral Screening:
| Procedure Code | Description |
| D0120 | Periodic oral evaluation |
| D1203 | Topical application of fluoride (prophylaxis not included) - child |
| D1330 | Oral hygiene instructions |
The following criteria still apply for the Periodic Oral Screening:
Prior approval is not required for these services. These services are billed on the CMS-1500 claim form or electronically through ECS. Refer to the claim examples listed below. Refer to the Basic Medicaid handout for additional billing instructions.
Claim Example 1: Periodic Oral
Screening as a Separate Procedure
Claim Example 2: Initial oral
Screening in Conjunction with an Office Visit
Claim Example 3: Initial Oral
Screening in Conjunction with a Health Check Screening
For health departments, these services are billed through HSIS. Refer to the HSIS screen entry examples.
Note: Medicaid will only allow reimbursement of these ADA codes if all three procedures are billed on the same claim for the same date of service.
Note: These procedure codes all begin with an alpha "D" character
followed by four numeric characters.
EDS, 1-800-688-6696 or 919-851-8888
A prescriber Medicaid identification number (ID) will be issued in lieu of the DEA number. The ID number follows the same format as the DEA number and will always begin with a Z (for example, ZF1234567).
Prescribers must enter this number on their Medicaid prescriptions. This number is referred to as a PRESCRIBER MEDICAID IDENTIFICATION NUMBER only, and should not be referred to as a DEA number.
If updated information has not been submitted to EDS Provider Enrollment, please copy, complete, and return the DEA Number form for each prescriber in your practice. Please send the information to the following address:
EDS Provider Enrollment Unit
P.O. Box 300009
Raleigh, North Carolina 27622
FAX: 919-851-4014
EDS, 1-800-688-6696 or 919-851-8888
Billing Guidelines
Nominal reimbursement is available for collecting samples for lab testing in addition to the amounts paid under the laboratory fee schedule. Only one collection fee is allowed for each venipuncture for each recipient encounter, regardless of the number of specimens drawn. When a series of specimens is required to complete a single test (e.g., glucose tolerance test), the series is treated as a single encounter. Only the provider who has extracted the specimen from the recipient may bill the collection code. Bill G0001 on the CMS-1500 claim under the RHC/FQHC's "C" suffix provider number.
Adjusting the Cost Report
The cost of the technical aspects of the test must be adjusted from
the cost report. These costs include associated space, equipment, supplies,
facility overhead, and personnel.
EDS, 1-800-688-6696 or 919-851-8888
EDS, 1-800-688-6696 or 919-851-8888
|
|
|
Code |
|
|
|
Maternity Care Coordination Initial |
|
Maternity care coordination |
|
|
Maternity Care Coordination Subsequent | ||
|
|
Maternity Care Coordination Home Visit | ||
|
|
Childbirth Education |
|
Childbirth education |
|
|
Maternal Care Skilled Nurse Home Visit |
|
Maternal care skilled nurse home visit |
|
|
Postpartum Home Visit |
|
Home visit for postnatal assessment and follow-up care |
|
|
Newborn Home Visit |
|
Home visit for newborn care and assessment |
|
|
Intensive Psychosocial Counseling |
|
Health and behavior intervention |
|
|
Child Service Coordination |
|
Child service coordination |
|
|
Maternal Outreach Worker Brief |
|
Maternal outreach worker services |
|
|
Maternal Outreach Worker Standard | ||
|
|
Maternal Outreach Worker Extended |
For a description of the policies relative to these new codes, please refer
to August 2002 Special Bulletin
IV, HIPAA Code Conversion. This information supersedes previously
published policies and guidelines.
EDS, 1-800-688-6696 or 919-851-8888
Some of the codes currently used will be replaced by multiple codes, and some will be deleted and replaced with existing codes. Read each description carefully to ensure that the correct size, quantity or preparation is billed. For example, the current code for gauze elastic bandages (Kling, Kerlix, roller gauze) is W4602 and is priced per roll; the replacement codes will be A6263, A6264, A6405, and A6406. The new codes are priced per linear yard.
Current codes shown below will be end-dated effective with date of service
September 30, 2002. The new codes will be effective with date of service
October 1, 2002.
|
|
|||
|
Code |
Code |
|
Rate/Unit |
| Dressing Supplies | |||
|
|
|
Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
$ 4.07
|
|
|
|
Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
.05
|
|
|
|
Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in. without adhesive border, each dressing |
.05
|
|
|
|
Gauze, elastic, non-sterile, all types, per linear yard |
.29
|
|
|
|
Gauze, non-elastic, non-sterile, per linear yard |
.48
|
|
|
|
Gauze, elastic, sterile, all types, per linear yard |
.33
|
|
|
|
Gauze, non-elastic, sterile, all types, per linear yard |
.79
|
|
|
|
Tape, waterproof, per 18 sq. in. |
6.73
|
| Intravenous Therapy and Parenteral Supplies | |||
|
|
|
Syringe with needle, sterile 5 cc or greater, each |
.31
|
|
|
|
Syringe, sterile, 20 cc or greater, each |
1.08
|
|
|
|
Lancets, per box of 100 |
12.68
|
| Miscellaneous Supplies | |||
|
|
|
Disposable underpads, all sizes (e.g., Chux's) |
$ 5.71
|
| Skin Care (Decubitus) Supplies | |||
|
W4621 |
|
Heel or elbow protector, each |
8.45
|
| Solutions | |||
|
|
|
Betadine or pHisoHex solution, per pint |
5.59
|
| Tracheostomy Supplies | |||
|
|
|
Tracheostomy tube holder |
4.07
|
|
|
|
Tracheostomy care kit for new tracheostomy |
6.01
|
|
|
|
Tracheostomy care kit for established tracheostomy |
4.73
|
* Denotes existing codes. Please note that these are existing codes replacing W4624.
Providers must bill their usual and customary charges.
Dot Ling, Medical Policy Section
DMA, 919-857-4021
| Monthly rental rate |
$ 20.97
|
| New purchase rate |
209.70
|
| Used purchase rate |
157.27
|
Prior approval is required. The lifetime expectancy of these legrests
is three years. Providers must bill their usual and customary charges.
Melody B. Yeargan, P.T., Medical Policy Section
DMA, 919-857-4020
Required changes and additional fields are:
00 = 12:00-12:59 Midnight 12 = 12:00-12:59 Noon
01 = 01:00-01:59 13 = 01:00-01:59
02 = 02:00-02:59 14 = 02:00-02:59
03 = 03:00-03:59 15 = 03:00-03:59
04 = 04:00-04:59 16 = 04:00-04:59
05 = 05:00-05:59 17 = 05:00-05:59
06 = 06:00-06:59 18 = 06:00-06:59
07 = 07:00-07:59 19 = 07:00-07:59
08 = 08:00-08:59 20 = 08:00-08:59
09 = 09:00-09:59 21 = 09:00-09:59
10 = 10:00-10:59 22 = 10:00-10:59
11 = 11:00-11:59 23 = 11:00-11:59
01 = Discharged to home or self care (routine discharge).
02 = Discharged/transferred to another short-term general hospital.
05 = Discharged/transferred to another type of institution for inpatient
care or referred for outpatient services to another institution.
07 = Left against medical advice.
20 = Expired.
30 = Still a patient or expected to return for outpatient services.
EDS, 1-800-688-6696 or 919-851-8888
Please ensure that each request corresponds to the instructions for completion of the CMN/PA form given in step 2 of subsection 6.4 of the N.C. Medicaid Durable Medical Equipment manual. It is not necessary to complete fields 3, 6, and 10. Entering ICD-9-CM codes in fields 11 and 12 and a CPT code in field 13 is optional. All of the remaining fields must be completed. Field 24 is required for the following HCPCS codes: E0202, E0607, E0608, E0609, E0480, E0650, E0651, E0652, E0784, E0935, W4006, and W4007.
N/A must only be used in the following fields under the following circumstances:
When completing field 26, be sure to fully identify the equipment that is being requested. The provider's return address must be entered in field 29. Failure to do so will delay the return of the form. A stamped address may be used. All of the information provided must be accurate and thorough.
Note: Each page of documentation with the CMN/PA must contain
the recipient's name and Medicaid identification (MID) number. Effective
immediately, EDS will retain all documentation attached to the CMN/PA and
the white (original) copy of the form. The yellow and pink copies will
be returned to the provider. It is the provider's responsibility to maintain
copies for their records.
EDS, 1-800-688-6696 or 919-851-8888
If a Medicaid recipient is physically unmanageable, medically compromised or severely mentally retarded and will not cooperate for treatment in the dental office, treatment can be completed in an Ambulatory Surgical Center (ASC). The ADA claim form is used by dentists for billing dental services. The dentist's billing instructions do not change, except for the place of service. Since the service is rendered in the ASC, the place of service code "F" must be entered in block 49 on the ADA claim form. Services that normally require prior approval are handled in the usual manner.
Ambulatory Surgical Center Providers
ASC bills for facility use. The ASC claims are filed on the CMS-1500
claim form. The facility rates for ambulatory dental services are priced
based on total time, utilizing ASC Groups 1 through 4, as outlined below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For ASC dental treatment, specific changes in ASC billing procedures are listed below:
Override requests must be submitted using the Override Request form and sent to EDS within six months of the date of service. EDS has 30 days to evaluate the request.
The Division of Medical Assistance (DMA) sends a monthly enrollment
report to each PCP to assist in identification of their enrollees. DMA
also sends a monthly referral report to each PCP so they can verify the
validity and accuracy of the referrals. PCPs must document all referrals
in the patient record. It is the responsibility of the PCP to review the
reports and report discrepancies to their regional Managed Care Consultant
for investigation.
Managed Care Section
DMA, 919-857-4022
Revision of a hospital UR plan is necessary only when one of the following occurs:
Division of Medical Assistance
Medical Policy Section
Hospital Utilization Review
2511 Mail Service Center
Raleigh, NC 27699-2511
Ann H. Kimbrell, R.N., Institutional Services
DMA, 919-857-4020
EDS, 1-800-688-6696 or 919-851-8888
After the trigger points have been reached, claims will not process without prior approval authorization.
Note: HMO and Medicare recipients are exempt from this policy.
Note: For Local Educational Agencies (LEAs), the prior approval process is deemed met by the IEP process.
Workshops for Outpatient Specialized Therapy Prior Approval Process
Detailed instructions about the prior approval process will be provided in workshops scheduled for September 2002. There is no charge for the workshops. However, to ensure adequate seating, please complete and submit the Outpatient Specialized Therapy Prior Approval Process Workshop registration form or register online beginning September 1, 2002, at http://www.mrnc.org under the News and Upcoming Events section. Workshops will begin at 10:00 a.m. and end at 1:00 p.m.
Please access and print the PDF version of the September 2002 Special Bulletin V, Outpatient Specialized Therapies, from the DMA website and bring it with you.
Registration form for the Outpatient
Specialized Therapy Prior Approval Process Workshops.
| September 10,
2002
Park Inn Gateway Conference Center 909 US Highway 70 SW Hickory, NC |
September 11,
2002
Hilton Greenville 207 Greenville Blvd SW Greenville, NC |
September
12, 2002
McKimmon Center Raleigh, NC |
Hilton - Greenville, North Carolina
Take Highway 264 East to Greenville. Turn right onto Allen Road in
Greenville. Travel approximately 2 miles. Allen Road becomes Greenville
Boulevard/Alternate 264. Follow Greenville Boulevard for 2½ miles
to the Hilton Greenville, which is located on the right.
McKimmon Center - Raleigh, North Carolina
Traveling East on I-40
Take exit 295 and turn left onto Gorman Street. Travel approximately
one mile. The McKimmon Center is located on the right between Avent Ferry
Road and Western Boulevard.
Traveling West on I-40
Take exit 295 and turn right onto Gorman Street. Travel approximately
one mile. The McKimmon Center is located on the right between Avent Ferry
Road and Western Boulevard.
Carol Robertson
Nora Poisella
Behavioral Health Services
DMA, 919-857-4020
The process for billing these services will be published in the September 2002 Special Bulletin VI, Medicare Part B, for use in the Medicare Part B seminar. However, the Division of Medical Assistance (DMA) is unable to print copies of special and general Medicaid bulletins for distribution to providers due to the State's severe budget problems. The Medicare Part B Special Bulletin will not be distributed to providers attending the seminars. Providers must access and print the PDF version of the September 2002 Special Bulletin VI, Medicare Part B and bring it to the seminar.
Due to limited seating, preregistration is required and limited to two staff members per office. Unregistered providers are welcome to attend when reserved space is adequate to accommodate. Providers may register for the Medicare Part B seminar by completing and submitting the Medicare Part B Seminar registration form or providers can register online. Please select the most convenient site and return the completed registration form to EDS as soon as possible. Seminars begin at 10:00 a.m. and end at 1:00 p.m. Providers are encouraged to arrive by 9:45 a.m. to complete registration.
| Wednesday, September
4, 2002
Holiday Inn Conference Center 530 Jake Alexander Blvd., S. Salisbury, NC |
Thursday, September 5,
2002
Ramada Inn Plaza 3050 University Parkway Winston-Salem, NC |
Tuesday, September 10,
2002
WakeMed Andrews Conference Center 3000 New Bern Avenue Raleigh, NC |
| Thursday, September
12, 2002
Blue Ridge Community College Bo Thomas Auditorium College Drive Flat Rock, NC |
Tuesday, September
17, 2002
Coast Line Convention Center 501 Nutt Street Wilmington, NC |
Wednesday,
September 18, 2002
Hilton Greenville 207 Greenville Blvd SW Greenville, NC |
Traveling North on I-85
Take exit 75. Turn left onto Jake Alexander Boulevard. Travel approximately
½ mile. The Holiday Inn is located on the right.
Ramada Inn Plaza - Winston-Salem, North Carolina
Take I-40 Business to the Cherry Street exit. Continue on Cherry Street
for approximately 2 to 3 miles. Turn left at the IHOP Restaurant. The Ramada
Inn Plaza is located on the right.
WakeMed Andrews Conference Center - Raleigh,
North Carolina
Driving and Parking Directions
Take the I-440 Raleigh Beltline to exit 13A, New Bern Avenue.
Paid parking ($3.00 maximum per day) is available on the top two levels of parking deck P3. To reach the parking deck, turn left at the fourth stoplight on New Bern Avenue, and then turn left at the first stop sign. Parking for oversized vehicles is available in the overflow lot for parking deck P3. Handicapped accessible parking is available in parking lot P4, directly in front of the conference center.
To enter the Andrews Conference Center, follow the sidewalk toward New Bern Avenue past the Medical Office Building to entrance E2 of the William F. Andrews Center for Medical Education.
Illegally parked vehicles will be towed. Parking is not permitted at East Square Medical Plaza, Wake County Human Services or in parking lot P4 (except for handicapped accessible parking).
Blue Ridge Community College - Flat Rock, North
Carolina
Take I-40 to Asheville. Travel east on I-26 to exit 22. Turn right
and then take the next right. Follow the signs to Blue Ridge Community
College. Turn left at the large Blue Ridge Community College sign. The
college is located on the right. Pass the college's main entrance and turn
right into the college entrance past the pond. The parking lot is on the
left.
Coast Line Convention Center - Wilmington,
North Carolina
Take I-40 east to Wilmington. Take the Highway 17 exit. Turn left onto
Market Street. Travel approximately 4 or 5 miles to Water Street. Turn
right onto Water Street. The Coast Line Inn is located one block from the
Hilton on Nutt Street behind the Railroad Museum.
Greenville Hilton - Greenville, North
Carolina
Take Highway 264 east to Greenville. Turn right onto Allen Road in
Greenville. Travel approximately 2 miles. Allen Road becomes Greenville
Boulevard/Alternate 264. Follow Greenville Boulevard for 2½ miles
to the Hilton Greenville, which is located on the right.
EDS, 1-800-688-6696 or 919-851-8888
| August 13, 2002 | September 4, 2002 | October 15, 2002 |
| August 20, 2002 | September 10, 2002 | October 22, 2002 |
| August 29, 2002 | September 17, 2002 | October 30, 2002 |
| September 26, 2002 |
| August 9, 2002 | August 30, 2002 | October 25, 2002 |
| August 16, 2002 | September 6, 2002 | October 18, 2002 |
| August 23, 2002 | September 13, 2002 | October 11, 2002 |
| September 20, 2002 |
Electronic claims must be transmitted and completed by 5:00 p.m. on the cut-off date to be included in the next checkwrite. Any claims transmitted after 5:00 p.m. will be processed on the second checkwrite following the transmission date.
| _____________________ | _____________________ | |
| Nina M. Yeager, Director | Ricky Pope | |
| Division of Medical Assitance | Executive Director | |
| Department of Health and Human Services | EDS |
| DMA Home |
|